Truist reiterates Buy on Affirm stock, lowers price target to $86
Truist reiterated a Buy rating on Affirm (AFRM) but lowered its price target to $86 from $88, citing lower fintech multiples. AFRM trades at $62.71, with Truist estimating 35% Q2 FY2027 GMV growth. Truist also adjusted EPS estimates, noting lower margins. Analysts have mixed views, with some raising targets and others lowering them due to credit concerns.
How this was made
The 30-second read
Why it matters
The main tradable input is the revised valuation framework (lower multiples) and the direction of estimate changes (higher GMV, lower margins/EPS, modestly lower take-rate expectations).
Market read
Provides a near-term sentiment and valuation reference point for AFRM, but it is not a new earnings or guidance release from the company.
What to watch
The note attributes changes to funding costs and credit provisions assumptions; traders may want to monitor whether actual credit performance and take-rate trends confirm or contradict these refreshed assumptions.
Background
The piece summarizes Truist Securities’ updated model for Affirm, including GMV growth, RLTC take rate expectations, and GAAP EPS changes, alongside other recent analyst target revisions.
Ticker impact
Truist reiterated a Buy on Affirm and cut its price target to $86, citing lower fintech-lender target multiples and updated GMV/EPS assumptions.
Likely mild upside bias from the reiterated Buy, partially offset by the reduced price target and the note of lower margins and funding/credit assumptions.
The article is an analyst note with a specific target cut and updated estimates (GMV growth, RLTC take rate, GAAP EPS), which can influence near-term sentiment but is not a new company disclosure.
Market effects
Highlights that fintech-lender valuation multiples have declined as investors weigh macro credit and regulatory risk, which can pressure the peer group’s multiples.
No specific regional market catalyst beyond US-listed fintech sentiment.
Limited, as the driver is US analyst valuation framing around credit/regulatory risk.
Counterpoint
The target cut and lower GAAP EPS estimate could signal that downside risks (margins, credit provisions) are being underappreciated, even if GMV growth expectations were raised.
Key entities
- companyAffirm Holdings
Subject of the analyst reiteration and price-target cut, with updated GMV, take-rate, and EPS assumptions.
- analyst_firmTruist Securities
Reiterated Buy and lowered the price target to $86, citing lower fintech-lender multiples and updated estimate drivers.



